21527-Solid Tumors-NA-22

Solid Tumors

A Phase 1b/2, Multicenter, Open-label Basket Study Evaluating the Safety and Efficacy of Bemarituzumab Monotherapy in Solid Tumors with FGFR2b Overexpression (FORTITUDE-301) (20210104)

  • Details

ClinicalTrials.gov ID: NCT05325866
Diagnosis Type: NA
USOR Number:

  • Address

1700 S Potomac Street
Aurora, CO 80012
P: (303) 418-7659

Search by practice name, trial titles, indicators and specific disease types.